1. Home
  2. CADL vs SITC Comparison

CADL vs SITC Comparison

Compare CADL & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.20

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo SITE Centers Corp.

SITC

SITE Centers Corp.

HOLD

Current Price

$5.57

Market Cap

297.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SITC
Founded
1999
1965
Country
United States
United States
Employees
N/A
155
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
297.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
SITC
Price
$6.20
$5.57
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$19.00
$8.00
AVG Volume (30 Days)
1.7M
605.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
122.06%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.09
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$5.24
52 Week High
$7.66
$12.74

Technical Indicators

Market Signals
Indicator
CADL
SITC
Relative Strength Index (RSI) 56.36 53.26
Support Level $5.42 $5.24
Resistance Level $6.41 $6.57
Average True Range (ATR) 0.48 0.10
MACD 0.09 0.05
Stochastic Oscillator 49.22 91.89

Price Performance

Historical Comparison
CADL
SITC

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.

Share on Social Networks: